DANCAN — Dancann Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK0.56m
- DKK0.06m
- DKK7.37m
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874
Brief: Dancann Pharma Announces Appointment Of Louise Conradsen As New Subsidiary CEO
Brief: Dancann Pharma Says Louise Conradsen Appointed As CEO Of Subsidiary Canngros ApS
Brief: Dancann Pharma A/S Announces The Appointment Of Louise Conradsen As New CEO
Brief: Dancann Pharma Says Shareholder Xignotus As A Result Of Acquisition Of Canngros Has Crossed Flagging Limit Of 25%
Brief: Dancann Pharma A/S Announces Its Intention To Carry Out Directed Issue Of Units
Brief: Dancann Pharma A/S Says Acquires CannGros ApS
Brief: DanCann Pharma A/S issues warrants to the executive management team
Brief: Dancann Pharma Q4 EBIT Loss Widens To DKK 2.7 Million
Brief: Dancann Pharma Signs LoI With Canadian Tetra Bio-Pharma
Brief: Dancann Pharma A/S Enter Exclusive Agreement With Cannassure Therapeutics
Brief: Dancann Pharma Q3 EBITA Up At DKK 2.3 Mln